Diabetes Care, Vol 17, Issue 12 1390-1396, Copyright © 1994 by American Diabetes Association

ARTICLES

Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study

T Danne, B Weber, R Hartmann, I Enders, W Burger and G Hovener
Children's Hospital, Kaiserin Auguste Victoria Haus, Klinikum Rudolf Virchow, Berlin, Germany.

OBJECTIVE--To assess the influence of long-term glycemic control on the development of background retinopathy in adolescents followed longitudinally from the onset of insulin-dependent diabetes mellitus (IDDM). RESEARCH DESIGN AND METHODS--Repeated retinal fluorescein angiographies, in intervals of 1-2 years, were evaluated prospectively in 346 patients (190 males, 156 females; 19.8 [8.8-35.4] years of age; diabetes duration of 10.4 [1.1-27.4] years at their latest eye examination, median [range]). The influences of long-term HbA1c (mean of 18 [1-95] determinations per person) and microalbuminuria (> or = 2 of > or = 3 measurements > or = 15 micrograms/min x 1.73 m2) were studied by multiple linear regression, life-table analysis, and trend analyses. RESULTS--The rate of background retinopathy per 100 patient-years increased with poorer glycemic control from 0.7 (long-term HbA1c < 7% to 7.3 (HbA1c > 11%) following an exponential function. Life-table analysis after subdivision in HbA1c quartiles of equal sizes (HbA1c < 8, 8-9, 9-10, and > 10%) revealed an individual median expectation of background retinopathy after more than 25, 16.2, 12.7, or 12.0 years of diabetes, respectively. However, significant differences were found only between 8-9% and 9-10%, calculated either as prevalence, life-table analysis, or relative incidence, thus suggesting that a threshold model may also fit the data. After 12 years of diabetes, < 25% of those patients exhibiting microalbuminuria (n = 18) were expected to be free from retinopathy compared with 81% of those with normoalbuminuria (n = 86). CONCLUSIONS--Two statistical models are appropriate to explain the relationship between glycemic control and risk for background retinopathy: 1) a continuous exponential relationship as described by the DCCT or 2) the presence of a threshold HbA1c level at 9%. Thus, diabetes treatment in children should aim at long-term HbA1c levels < 9.0%, but every progress closer to normal may further reduce the risk.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Danne, K. Lange, and O. Kordonouri New developments in the treatment of type 1 diabetes in children Arch. Dis. Child., November 1, 2007; 92(11): 1015 - 1019. [Full Text] [PDF]

				A. Maguire, A. Chan, J. Cusumano, S. Hing, M. Craig, M. Silink, N. Howard, and K. Donaghue The Case for Biennial Retinopathy Screening in Children and Adolescents Diabetes Care, March 1, 2005; 28(3): 509 - 513. [Abstract] [Full Text] [PDF]

				J. Silverstein, G. Klingensmith, K. Copeland, L. Plotnick, F. Kaufman, L. Laffel, L. Deeb, M. Grey, B. Anderson, L. A. Holzmeister, et al. Care of Children and Adolescents With Type 1 Diabetes: A statement of the American Diabetes Association Diabetes Care, January 1, 2005; 28(1): 186 - 212. [Full Text] [PDF]

				M. Svensson, J. W. Eriksson, and G. Dahlquist Early Glycemic Control, Age at Onset, and Development of Microvascular Complications in Childhood-Onset Type 1 Diabetes: A population-based study in northern Sweden Diabetes Care, April 1, 2004; 27(4): 955 - 962. [Abstract] [Full Text] [PDF]

				B. M. Svoren, D. Butler, B.-S. Levine, B. J. Anderson, and L. M. B. Laffel Reducing Acute Adverse Outcomes in Youths With Type 1 Diabetes: A Randomized, Controlled Trial Pediatrics, October 1, 2003; 112(4): 914 - 922. [Abstract] [Full Text] [PDF]

				C J Schultz, R Amin, and D B Dunger Markers of microvascular complications in insulin dependent diabetes Arch. Dis. Child., July 1, 2002; 87(1): 10 - 12. [Full Text] [PDF]

				M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications Diabetes Care, January 1, 2002; 25(1): 148 - 198. [Full Text] [PDF]

				N. Chaturvedi, A.-K. Sjoelie, M. Porta, S. J. Aldington, J. H. Fuller, M. Songini, and E. M. Kohner Markers of Insulin Resistance Are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study Diabetes Care, February 1, 2001; 24(2): 284 - 289. [Abstract] [Full Text]

				J. H. Warram, J. E. Manson, and A. S. Krolewski Glycosylated Hemoglobin and the Risk of Retinopathy in Insulin-Dependent Diabetes Mellitus N. Engl. J. Med., May 11, 1995; 332(19): 1305 - 1306. [Full Text]